Skip to main content
Download PDF

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives

Biomarker Research volume 10, Article number: 90 (2022) Cite this article

The Original Article was published on 07 December 2022

Correction: Biomark Res 10, 89 (2022)

https://doi.org/10.1186/s40364-022-00436-7

The original article [1] contains an error in the following sentence:

‘When combining IMQ, photodynamic therapy (PDT) had a better effect on cutaneous squamous cell carcinoma (cSCC) than either IMQ or PDT alone.’

The mention of IMQ is erroneous and should instead be IMA (imatinib mesylate).

Reference

  1. Sun H, et al. Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. Biomark Res. 2022;10:89. https://doi.org/10.1186/s40364-022-00436-7.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Hao Sun, Yingmei Li and Peng Zhang contributed equally to this work.

Authors and Affiliations

  1. Department of Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China

    Hao Sun

  2. Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China

    Yingmei Li, Haizhou Xing, Yongping Song, Dingming Wan & Jifeng Yu

  3. Department of Thoracic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China

    Peng Zhang & Song Zhao

  4. Henan International Joint Laboratory of Nuclear Protein Gene Regulation, Henan University College of Medicine, Kaifeng, 475004, Henan, China

    Jifeng Yu

Authors
  1. Hao Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingmei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Haizhou Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Song Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yongping Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dingming Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jifeng Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yongping Song, Dingming Wan or Jifeng Yu.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, H., Li, Y., Zhang, P. et al. Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. Biomark Res 10, 90 (2022). https://doi.org/10.1186/s40364-022-00445-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40364-022-00445-6

Biomarker Research

ISSN: 2050-7771

Contact us